BRIEF published on 09/13/2025 at 01:05, 1 year 1 month ago BioNxt Settles Debt with Share and Cash Agreement Debt Settlement Canadian Securities Exchange Regulatory Approvals BioNxt Solutions Share Agreement
BRIEF published on 09/13/2025 at 01:05, 1 year 1 month ago BioNxt règle sa dette grâce à un accord en actions et en espèces Bourse Des Valeurs Canadiennes Approbations Réglementaires Règlement De La Dette Solutions BioNxt Accord De Partage
PRESS RELEASE published on 09/13/2025 at 01:00, 1 year 1 month ago BioNxt Announces Shares for Debt Settlement BioNxt Solutions Inc. announces a debt settlement agreement with a creditor, issuing common shares and making a cash payment. Company focuses on bioscience innovations and drug delivery technologies Innovation Debt Settlement BioScience Drug Delivery BioNxt
BRIEF published on 09/05/2025 at 09:10, 1 year 2 months ago BioNxt Solutions fait ses débuts sur le marché OTCQB Divulgation Financière Marché OTCQB Développement De Médicaments Investisseurs Américains Solutions BioNxt
BRIEF published on 09/05/2025 at 09:10, 1 year 2 months ago BioNxt Solutions Debuts on OTCQB Market Financial Disclosure Drug Development US Investors BioNxt Solutions OTCQB Market
PRESS RELEASE published on 09/05/2025 at 09:05, 1 year 2 months ago BioNxt Solutions Completes Up-Listing to The OTCQB Market BioNxt Solutions Inc. announces up-listing to OTCQB market, expanding access to US investors. Three drug development programs underway in Europe & North America. Company focuses on innovative drug delivery platforms Drug Development BioNxt Solutions Inc. US Investors OTCQB Market Innovative Drug Delivery
BRIEF published on 09/02/2025 at 09:10, 1 year 2 months ago BioNxt Begins Lab-Scale Development of Semaglutide Oral Film Drug Delivery BioNxt Solutions Semaglutide ODF Lab-scale Formulation Patent Development
BRIEF published on 09/02/2025 at 09:10, 1 year 2 months ago BioNxt commence le développement à l'échelle du laboratoire d'un film oral à base de sémaglutide Solutions BioNxt Administration De Médicaments Semaglutide ODF Formulation À L'échelle Du Laboratoire Développement De Brevets
PRESS RELEASE published on 09/02/2025 at 09:05, 1 year 2 months ago Semaglutide API Delivery Enables Start of Lab-Scale ODF Development at BioNxt BioNxt Solutions announces receipt of Semaglutide API for laboratory-scale testing of ODF delivery system. Collaboration with Gen Plus for European drug development hub BioNxt Solutions Semaglutide API ODF Delivery System Laboratory-scale Testing Gen Plus
BRIEF published on 08/23/2025 at 02:10, 1 year 2 months ago BioNxt Solutions Engages in Investor Relations Initiatives Brand Visibility Investor Relations BioNxt Solutions Apaton Finance Cayo Ventures
Published on 11/10/2026 at 02:45, 1 hour 53 minutes ago Presentation to Zurich Precious Metals Summit
Published on 11/09/2026 at 23:10, 5 hours 28 minutes ago Ur-Energy Reports Third Quarter 2026 Results
Published on 11/09/2026 at 23:00, 5 hours 38 minutes ago LNG Energy Group Announces Issuance of Third Partial Revocation Order and Proposed Shares-for-Debt Settlement
Published on 11/09/2026 at 22:32, 6 hours 6 minutes ago Announces Extension for Closing of Private Placement of Convertible Promissory Notes
Published on 11/09/2026 at 22:15, 6 hours 23 minutes ago Goldcliff Announces Closing of the Second and Final Tranche of its "LIFE" Offering and Completion of Drilling at Kettle Valley
Published on 11/10/2026 at 01:20, 3 hours 18 minutes ago US defence customer steps up orders and first graphene oxide orders secured
Published on 11/09/2026 at 22:54, 5 hours 44 minutes ago EQS-Adhoc: Northern Data Group reports Q3 2026 and raises its FY 2026 revenue outlook communicated on 17 June 2026
Published on 11/09/2026 at 22:10, 6 hours 28 minutes ago Quantinuum to Participate in the Cantor Convergence 4th Annual Crypto, FinTech, AI & Energy Infrastructure Conference
Published on 11/09/2026 at 22:05, 6 hours 33 minutes ago Mayr-Melnhof Karton AG: MM Group to sell majority stake in its Packaging business to KPS Capital Partners and plans a special distribution to shareholders
Published on 11/09/2026 at 18:30, 10 hours 8 minutes ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond
Published on 11/09/2026 at 18:30, 10 hours 8 minutes ago Air Liquide a réalisé avec succès une émission obligataire multi-tranches de 390 millions de CHF
Published on 11/09/2026 at 17:45, 10 hours 53 minutes ago Déclaration hebdomadaire de rachat d'actions
Published on 11/09/2026 at 17:45, 10 hours 53 minutes ago Déclaration des droits de vote à fin octobre 2026
